Cadila Healthcare Shares Record 3 Percent Surge After EIR Report

The rise in the share came on the heels of the firm’s Baddi unit located in Himachal Pradesh getting an establishment inspection report (EIR) from the United States Food and Drug Administration (USFDA). The audit had given nil observations with no action indicated classification (NAI).

from Top Business News- News18.com https://ift.tt/2XDJ4TX

• Tweet
• Share
• Share
• Share
• Share